COVID-19 vaccine fathers: There will be enough vaccines for the whole world and we will win the pandemic in the third quarter of 2021.

Tram Ho

In an interview with the BBC yesterday, Professor Ugur Sahin, a German scientist and one of the ” father” of the COVID-19 vaccine produced by Pfizer and BioNTech said: We can return to normal within 1 year.

Sahin is a co-founder and CEO of biotech company BioNTech. Last week, BioNTech together with Pfizer announced the results of a phase III clinical trial on more than 43,500 volunteers showing that the COVID-19 vaccine they are developing is more than 90% effective.

This was an unexpected figure that led Pfizer’s chairman and CEO, Dr. Albert Bourla, to say: “It’s been a great day for science and humanity”.

The prospects for the current COVID-19 vaccine candidates are currently very good. Yesterday, another US biotech company, Morderna , announced that the COVID-19 vaccine candidate they are developing had a 94.5% protection rate. Earlier, the Gamaleya Research Institute of the Russian Federation also said their COVID-19 vaccine Sputnik V is 92% more effective.

Professor Ugur Sahin said that if the COVID-19 vaccines are effectively distributed and there are enough people who inject them, the COVID-19 pandemic will cool down and things can return to normal by winter. after.

Cha đẻ vắc-xin COVID-19: Sẽ có đủ vắc-xin cho cả thế giới và chúng ta sẽ chiến thắng đại dịch vào quý III năm 2021 - Ảnh 1.

Professor Ugur Sahin, co-founder and CEO of biotech company BioNTech

Sahin’s prediction is the answer to the question of BBC host Andrew Marr. He asked: From the creator of the COVID-19 vaccine, “do you see if the world can return to normal? And if so, when?”

Sahin said the vaccine trials of Pfizer and BioNTech are now raising hope for humanity. But as the number of people vaccinated this year is small, we are still going through a “tough winter”.

“Although there is a vaccine, we cannot lower the number of COVID-19 infections this winter,” said Professor Sahin. “But if things go well, we will start providing the vaccine and later this year, early next year. Our goal is to provide more than 300 million doses of the vaccine for April irrigation. year. And this number is enough to start making an impact. “

Professor Sahin said the goal of the vaccine distribution and the mass vaccination is “extremely essential”. And we have to get it by next fall. ” I believe we will achieve that because there are a number of vaccine companies that are helping us increase supply ,” he said. “We’ll probably have a normal winter next year.”

Will the world have enough vaccines and will America return to normal first?

Earlier, Pfizer said it expected to deliver about 50 million doses of COVID-19 vaccine worldwide this year and up to 1.3 billion doses by the end of 2021. COVID-19 Vaccine They need two doses, which means 300 million doses will be enough for 150 million people and 1.3 billion doses enough for 650 million others.

Moderna, the tech company that claims its COVID-19 vaccine is up to 95% effective, says it could ship 20 million doses by the end of this year and between 500 million and 1 billion doses by 2021. .

Binnopharm, a factory involved in the production of the COVID-19 Sputnik V vaccine developed by Russia, also said it could produce 500 million doses by 2021.

Cha đẻ vắc-xin COVID-19: Sẽ có đủ vắc-xin cho cả thế giới và chúng ta sẽ chiến thắng đại dịch vào quý III năm 2021 - Ảnh 2.

So, taking into account the three vaccine candidates who announced the results of Phase III clinical trials alone, the world has 2.8 billion doses that can be distributed in 2021. Three vaccine candidates. Other potential COVID-19 applicants also said they could achieve a total capacity of 1 billion doses per year, including British AstraZeneca (400 million doses), Johnson & Johnson of America (300 million doses and Sinopharm of China). 300 million doses).

With these numbers, health experts say the world may have enough COVID-19 vaccine. However, they also worry that the countries that produced the first vaccines are more likely to stockpile the shots to vaccinate their populations first. This happened during the 2009 H1N1 epidemic.

The United States is currently the leader in the COVID-19 vaccine race. They currently have two vaccine candidates claiming efficacy above 90 and 94.5%. The two vaccines would give the United States an edge in its fight with COVID-19.

Dr. Anthony Fauci, America’s leading infectious disease specialist, said the United States could return to “relatively normal ” in the ” second and third quarter ” of 2021 if the majority of Americans were vaccinated. -please.

Certainly, COVID-19 will not be a pandemic that will last much longer because I believe vaccines will turn things around ,” he said.

Consult Businessinsider

Share the news now

Source : Genk